PSUF
BIO icon

People's United Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

People's United Financial’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.05M Sell
1,873
-1,409
-43% -$849K 0.03% 316
2021
Q4 		$2.48M Sell
3,282
-2,554
-44% -$1.91M 0.06% 211
2021
Q3 		$4.35M Sell
5,836
-34
-0.6% -$25.5K 0.1% 170
2021
Q2 		$3.78M Sell
5,870
-60
-1% -$36.5K 0.08% 179
2021
Q1 		$3.39M Buy
5,930
+108
+2% +$64K 0.08% 184
2020
Q4 		$3.39M Buy
5,822
+266
+5% +$151K 0.08% 169
2020
Q3 		$2.86M Buy
5,556
+2,756
+98% +$1.4M 0.08% 168
2020
Q2 		$1.26M Buy
2,800
+563
+25% +$248K 0.04% 257
2020
Q1 		$784K Buy
2,237
+52
+2% +$19.1K 0.03% 300
2019
Q4 		$809K Buy
2,185
+45
+2% +$15.9K 0.02% 402
2019
Q3 		$712K Sell
2,140
-16
-0.7% -$5.22K 0.02% 447
2019
Q2 		$674K Sell
2,156
-1,200
-36% -$359K 0.02% 467
2019
Q1 		$1.03M Buy
3,356
+1,070
+47% +$289K 0.03% 380
2018
Q4 		$532K Buy
+2,286
New +$613K 0.02% 493

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

People's United Financial's BIO Position: Q1 2022 in Review

People's United Financial reduced its Bio-Rad Laboratories Class A (BIO) stake by 43% in Q1 2022, selling an estimated $849K and leaving 1,873 shares worth $1.05M. The position accounts for 0.03% of the portfolio, ranked #316.

People's United Financial first reported a position in BIO in Q4 2018 and has held it in 14 quarters since. The position peaked at $4.35M in Q3 2021. 516 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

  • People's United Financial held 1,873 shares of Bio-Rad Laboratories Class A worth $1.05M as of Q1 2022.
  • People's United Financial sold 1,409 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $849K.
  • Bio-Rad Laboratories Class A made up 0.03% of People's United Financial's portfolio in Q1 2022, its #316 holding.
  • People's United Financial first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and has held it in 14 quarters since.
  • People's United Financial's Bio-Rad Laboratories Class A position peaked at $4.35M in Q3 2021.
  • 516 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.